Table 1.
Demographic and clinical data of mild, moderate and severe patients.
| Mild (n = 5) | Moderate (n = 20) | Severe (n = 20) | |
|---|---|---|---|
| Age, y (mean ± SD) | 48 ± 7,02 | 66 ± 16,04 | 65 ± 9,20 |
| Gender | |||
| Female | 2 (40%) | 10 (50%) | 6 (30%) |
| Male | 3 (60%) | 10 (50%) | 14 (70%) |
| Comorbidities | |||
| None | 4 (80%) | 5 (25%) | 2 (10%) |
| 1 | – | 2 (10%) | 3 (15%) |
| >1 | 1 (20%) | 13 (65%) | 18 (75%) |
| Cardiovascular disease | |||
| Hypertension | 1 (20%) | 12 (60%) | 12 (60%) |
| Coronary artery disease | – | 1 (5%) | 2 (10%) |
| Stroke | – | 1 (5%) | 1 (5%) |
| Metabolic disease | |||
| Obesity | 1 (20%) | 2 (10%) | 3 (15%) |
| Dyslipidemia | 1 (20%) | 4 (20%) | 7 (35%) |
| Hyperuricemia | – | – | 2 (10%) |
| Diabetes | – | 4 (20%) | 5 (25%) |
| Chronic respiratory disease | |||
| Asthma | – | – | 1 (5%) |
| Chronic obstructive pulmonary disease | – | 1 (5%) | – |
| Obstructive sleep apnea | – | 1 (5%) | 2 (10%) |
| Neoplasma | – | 2 (10%) | 3 (15%) |
| Others | – | 2 (8%) b | 1 (4%)c |
| Outcome | |||
| Death | 0 | 0 | 15 (75%) |
| Discharged alive | 0 | 20 (100%) | 3 (12%) |
| Still in hospital | 0 | 0 | 2 (10%) |
| Outpatient | 5 (100%) | 0 | 0 |
a
without active treatment, cured, remission; bSLE, thalassemia minor; chemochromatosis.